Results 1 -
10
of
22
for
Rituximab
- Riabni® (rituximab-arrx) ... Rituxan® (rituximab) ... Ruxience® (rituximab-pvvr) ... Truxima® (rituximab-abbs) ... Rituximab injection products are used in adults alone or with other medications to treat various types of ...
- Rituximab and hyaluronidase human injection is used alone or with other medications to treat various types of ... of white blood cells that normally fights infection). Rituximab and hyaluronidase human injection is also used with ...
- Ibritumomab injection is used with rituximab (Rituxan) to treat certain types of non-Hodgkin's lymphoma (NHL; cancer that begins in the cells of the immune system) that ...
- Idelalisib is used along with another medication rituximab (Rituxan) to treat chronic lymphocytic leukemia (CLL; a type of cancer that begins in the white blood cells) in people whose cancer came ...
- ... alone or in combination with obinutuzumab (Gazyva) or rituximab (Rituxan) to treat certain types of chronic lymphocytic ...
- ... is used along with bendamustine (Belrapzo, Treanda) and rituximab (Rituxan) in adults to treat a certain type ...
- ... used to reduce the dose of corticosteroids. Belimumab, rituximab, and anifrolumab are biologic medicines that may be ... a short course of 3 to 6 months. Rituximab is used in some cases as well. Blood ...
- ... may improve the low neutrophil count. The drug rituximab has been successful in people who do not ... treatment of refractory neutropenia in Felty's syndrome with rituximab. Scand J Rheumatol . 2018;47(4):340-341. ...
- ... and other medicines that suppress the immune system. Rituximab is an effective drug and has fewer risks ... Cyclophosphamide is used in life-threatening conditions where rituximab is not working or available. This medicine was ...
- National Institute of Environmental Health Sciences (National Institute of Environmental Health Sciences)... data repository in development February 18, 2005: The Rituximab In Myositis (RIM) Study January 16, 2008: Classification ... March 7, 2005: Investigative Opportunities in the RIM (Rituximab in Myositis) Study May 12, 2015: 1st International ...